| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2024 | May 24, 2024 | Trevi Therapeutics, Inc. | CFO | Sell | 46.3 | -4,350 | -7.55% | ✗ | $11.5K |
| Oct 11, 2023 | Oct 12, 2023 | Trevi Therapeutics, Inc. | CFO | Sell | 46.3 | -785 | -2.14% | ✓ | $1.6K |
| Sep 11, 2023 | Sep 13, 2023 | Trevi Therapeutics, Inc. | CFO | Sell | 46.3 | -711 | -2.03% | ✓ | $1.6K |
| Aug 11, 2023 | Aug 14, 2023 | Trevi Therapeutics, Inc. | CFO | Sell | 46.3 | -682 | -2.04% | ✓ | $1.6K |
| Jul 11, 2023 | Jul 12, 2023 | Trevi Therapeutics, Inc. | CFO | Sell | 46.3 | -687 | -2.15% | ✓ | $1.6K |
| Jun 12, 2023 | Jun 14, 2023 | Trevi Therapeutics, Inc. | CFO | Sell | 46.3 | -610 | -2.02% | ✓ | $1.6K |
| May 11, 2023 | May 15, 2023 | Trevi Therapeutics, Inc. | CFO | Sell | 50.0 | -562 | -1.97% | ✓ | $1.6K |
| Apr 11, 2023 | Apr 12, 2023 | Trevi Therapeutics, Inc. | CFO | Sell | 42.5 | -840 | -3.11% | ✓ | $1.5K |
| Mar 13, 2023 | Mar 15, 2023 | Trevi Therapeutics, Inc. | CFO | Sell | 42.5 | -892 | -3.48% | ✓ | $1.6K |
| Feb 13, 2023 | Feb 15, 2023 | Trevi Therapeutics, Inc. | CFO | Sell | 13.8 | -8,474 | -26.64% | ✓ | $20.8K |